A detailed history of Smithfield Trust CO transactions in Moderna, Inc. stock. As of the latest transaction made, Smithfield Trust CO holds 20 shares of MRNA stock, worth $2,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$2,319
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$69.51 - $104.43 $6,255 - $9,398
-90 Reduced 81.82%
20 $2,000
Q3 2023

Nov 06, 2023

BUY
$96.41 - $126.61 $8,676 - $11,394
90 Added 450.0%
110 $11,000
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $11,968 - $19,531
-53 Reduced 72.6%
20 $5,000
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $2,165 - $5,840
73 New
73 $4,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Smithfield Trust CO Portfolio

Follow Smithfield Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.